MNPR
Monopar Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.58 / 10
Netural
Technical analysis is neutral (3.58/10). A bullish long lower shadow is offset by bearish RSI overbought and MACD death cross signals, indicating short-term volatility without a clear directional bias.
Analysis Checks(1/4)
Long Lower Shadow
Score6.68/10
Win Rate57.50%
Hist. Signals80
Avg Return1.12%
Score6.68/10
Win Rate57.50%
Hist. Signals80
Avg Return1.12%
MACD Death Cross
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-3.12%
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-3.12%
RSI Overbought
Score4.33/10
Win Rate50.00%
Hist. Signals20
Avg Return3.84%
Score4.33/10
Win Rate50.00%
Hist. Signals20
Avg Return3.84%
Marubozu White
Score2.31/10
Win Rate41.67%
Hist. Signals24
Avg Return0.72%
Score2.31/10
Win Rate41.67%
Hist. Signals24
Avg Return0.72%
Long Lower Shadow
Score6.68/10
Win Rate57.50%
Hist. Signals80
Avg Return1.12%
Score6.68/10
Win Rate57.50%
Hist. Signals80
Avg Return1.12%
RSI Overbought
Score4.33/10
Win Rate50.00%
Hist. Signals20
Avg Return3.84%
Score4.33/10
Win Rate50.00%
Hist. Signals20
Avg Return3.84%
MACD Death Cross
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-3.12%
Score1/10
Win Rate37.50%
Hist. Signals8
Avg Return-3.12%
Marubozu White
Score2.31/10
Win Rate41.67%
Hist. Signals24
Avg Return0.72%
Score2.31/10
Win Rate41.67%
Hist. Signals24
Avg Return0.72%
What is the current technical signals for MNPR?
- MNPR presents a Netural setup with a Technical Score of 3.58/10. Key technical indicators highlight an RSI of 36.50 and a MACD of -2.14, with the trend anchored by the 50-Day SMA at 70.35. Traders should monitor key support at 55.27 and resistance at 59.44.
